We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PJT:NYSEPJT Partners Inc. analysis

Data as of Oct 21, 2026 - not real-time

Latest price
$136.94
Risk: medium
6/10Medium risk

Summary

The moving-average structure behind PJT Partners Inc. is neutral at $136.94, with no clear ordering between short and long averages. It has lost 24.8% over the past 30 days. RSI sits at 35.6, which reads as approaching oversold, and MACD momentum is bullish. The recent range runs from support at $131.37 up to resistance at $152.82.
The shares look overvalued, trading on 18.7 times earnings above a sector average of 15.9. The average analyst target implies 17.6% above today's level. Revenue is growing at 19.5% on a 10.6% profit margin. The 0.73% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 27.8%, a beta of 0.98 and a maximum drawdown of 32.6%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top market events

  • PJT Partners Inc PJT achieves historic revenue growth while navigating increased expenses and market volatility.
  • One analyst downgraded the stock to the equivalent of hold.
  • Kalkine Media1monPJT Partners CFO Helen T.

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading below the 200-day average of 157.89
  • MACD momentum is positive
  • 30-day price change of -24.8%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 18.7 versus sector average of 15.9
  • Trading below the 200-day average of 157.89
  • Analyst targets imply +17.6% versus the current price

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 18.7 versus sector average of 15.9
  • Analyst targets imply +17.6% versus the current price
  • Revenue growth of +19.5%

Key metrics

Financial health

Revenue Growth19.50%
Profit Margin10.58%
P/E Ratio18.7
ROE37.63%
ROA21.10%
Debt/Equity42.65
P/B Ratio11.2
Op. Cash Flow$713.0M
Industry P/E15.9

Technical analysis

TrendNeutral
RSI35.6
Support$131.37
Resistance$152.82
MA 20$140.42
MA 50$158.64
MA 200$157.89
MACDBullish
VolumeIncreasing
Fear & Greed Index90.52

Valuation

Fair Value$306.93
Target Price$161.11
Upside/Downside17.65%
GradeOvervalued
TypeGrowth
Dividend Yield0.73%

Risk assessment

Beta0.98
Volatility27.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.